13 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Electronic PHES vs Paper-based PHES for Hepatic EncephalopathyBrain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorderNot yet recruitingNot applicable2026-10-01NCT07852416
A Study of ATG-201 in Adult Participants With Autoimmune DiseasesSjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, skin disorder, systemic lupus erythematosus, systemic sclerosisNot yet recruitingPhase 12026-09-21NCT07732309
Study on the Treatment of Adolescent Patients With Seasonal Allergic RhinitisHypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitisRecruitingPhase 32026-09-03NCT07678931
Clinical Study of Cizutamig in Systemic Lupus ErythematosusSkin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosusRecruitingPhase 12026-09-02NCT07215663
A Phase II Trial of LM103 in Advanced MelanomaAdvanced MelanomaRecruitingPhase 22026-08-31NCT07310784
A Trial to Explore the Efficacy and Safety of O-triple as Initial Therapy in the Active Lupus Nephritis Patients (INITIAL Trial)Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorderNot yet recruitingPhase 32026-08-26NCT07767188
SPH5030 Tablets in Subjects With Advanced Her2-positive Solid TumorsHER2-positive Advanced Solid TumorsRecruitingEarly phase 12026-05-05NCT05245058
Left Ventricular Myocardial Work for Predicting Response to CRTcardiovascular disorder, heart disorder, heart failureNot yet recruitingNot stated2026-01-06NCT07319065
A Clinical Study to Evaluate LVIVO-TaVec200 for the Treatment of Relapsed/Refractory Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingEarly phase 12025-12-19NCT07294625
Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunctioncardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorderRecruitingPhase 42025-11-25NCT07110415
A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiographycardiovascular disorderRecruitingNot stated2025-08-21NCT07133516
Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High RiskDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmNot yet recruitingNot applicable2025-06-08NCT07010588
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).Type1 Diabetes MellitusNot yet recruitingNot stated2024-09-23NCT06606509